Skip to main content
Premium Trial:

Request an Annual Quote

Tute Genomics Raises $1.5M in Seed Round Funding

NEW YORK (GenomeWeb News) – Tute Genomics said this week that it has raised $1.5 million in a seed round of funding to advance its genome analysis software.

The company also said that it raised an additional $300,000 from AngelList, a fundraising platform for startups, through its new syndicate mechanism.

Investors in the seed round included Wilmington Pharmatech, Salt Lake Life Science Angels, Peak Ventures, Park City Angel Network, and individual angel investors.

Tute Genomics launched its first product for the next-generation sequencing data analysis space in the fall, as BioInform reported recently. The cloud-based genome interpretation platform "derives from the expertise underlying the ANNOVAR technology," which is an open-source program for functionally annotating variants found in species such as human, mouse, work, fly, and yeast.

ANNOVAR is written by Tute Genomics President Kai Wang, and the software uses proprietary machine-learning algorithms to prioritize clinically relevant genetic variants, genes, and pathways leading to improved disease gene and biomarker discovery work, the Salt Lake City-based company said.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.